- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Insight 305 results
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Energy Industry
Feature
January 22, 2021
General Counsel Internal Investigations Decision Tree for the Technology Industry
Feature
January 21, 2021
General Counsel Internal Investigations Decision Tree for the Financial Services Industry
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Food and Beverage Industry
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
Feature
January 15, 2021
General Counsel’s Decision Tree
Article · Source: Law360
January 5, 2021
A Legislative Solution For Medicare Claims Settlement Delays
Client Alert
January 4, 2021
FDA Establishes – And HHS Immediately Withdraws – New OTC Drug User Fee Rates
Newsletter
January 4, 2021
Health Headlines – January 4, 2021
Client Alert
December 31, 2020
Final Rule on VBP, Patient Assistance and Line Extensions Presents Opportunity and Risk for Drug Manufacturers
Newsletter
December 28, 2020
Health Headlines – December 28, 2020
Newsletter
December 21, 2020
Health Headlines – December 21, 2020
Client Alert
December 17, 2020
CMS Proposes New DMEPOS Coverage Policies and Payment Rates, and Seeks to Codify HCPCS Application, Benefit Category and Payment Determination Processes
Client Alert
December 14, 2020
HHS Finalizes 340B Administrative Dispute Resolution Process
Newsletter
December 14, 2020
Health Headlines – December 14, 2020
Client Alert
December 11, 2020
Department of Justice Vows Vigorous Enforcement of Clinical Trial Fraud
Newsletter
December 7, 2020
Health Headlines – December 7, 2020
Thought Leadership
December 2, 2020
Key Takeaways From the 13th Annual King & Spalding Medical Device Summit
Client Alert
November 30, 2020
Europe – Towards a More Harmonized Market for CBD?
Newsletter
November 30, 2020
Health Headlines – November 30, 2020
Client Alert
November 25, 2020
HHS Finalizes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
Client Alert
November 24, 2020
Are Pharma Speaker Programs Facing an Existential Crisis?
Newsletter
November 23, 2020
Health Headlines – November 23, 2020
Client Alert
November 23, 2020
He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform
Article · Source: Food and Drug Law Institute
November 20, 2020
That Will Leave a Mark: FDA’s Shifting Approach to Regulating the Coronavirus Testing Market Creates Confusion, Opportunities, and Enforcement Risk
Article · Source: For the Defense
November 17, 2020
An Evolving Landscape: The FDA's Regulation of Cannabis
Newsletter
November 16, 2020
Health Headlines – November 16, 2020
Newsletter
November 9, 2020
Health Headlines – November 9, 2020
Newsletter
November 2, 2020
Health Headlines – November 2, 2020
Client Alert
October 26, 2020
France - Trial Period for Medical Use of Cannabis-Based Products
Article · Source: Law360
October 26, 2020
Avoiding Shareholder Class Actions After FDA Drug Denials
Newsletter
October 26, 2020
Health Headlines – October 26, 2020
Newsletter
October 19, 2020
Health Headlines – October 19, 2020
Client Alert
October 6, 2020
FDA Announces Updates to Two Guidance Documents Concerning Breast Implant Safety and Transparency
Client Alert
October 5, 2020
EUROPE – The General Court Limits the Scope of “Satisfactory Methods” That Must Be Compared for Orphan Drug Designation
Client Alert
October 2, 2020
FDA Finalizes Rule and Guidance to Implement Safe Importation Action Plan Aimed at Lowering Prescription Drug Prices
Newsletter
September 28, 2020
Health Headlines – September 28, 2020
Client Alert
September 24, 2020
FDA Proposes New Rule Modifying its “Intended Use” Regulations
Newsletter
September 21, 2020
Health Headlines – September 21, 2020
Client Alert
September 10, 2020
EUROPE – Are Revisions of the Orphan Drug Regulation and Adoption of a Regulation on “Unmet Medical Needs” on the Horizon
Newsletter
September 8, 2020
Health Headlines – September 8, 2020
Article · Source: Pratt's Privacy & Cybersecurity Law Report
September 4, 2020
Congress Introduces Two Privacy Bills to Regulate COVID-19 Related Data
Client Alert
September 3, 2020
New FDA Guidance on Control of Nitrosamine Impurities
Client Alert
September 1, 2020
FDA Continues its Focus on Breast Implant Safety and Transparency with an Eye Toward Improving Regulatory Decision-Making
Newsletter
August 31, 2020
Health Headlines – August 31, 2020
Client Alert
August 25, 2020
Court Dismisses Shareholder Suit Seeking To Recover Stock Drop from FDA Nonapproval of Experimental Drug
Client Alert
August 24, 2020
France – Thresholds for Prior Authorization of Agreements with Healthcare Professionals and for Benefits of Low Value are Finally Out
Newsletter
August 24, 2020
Health Headlines – August 24, 2020
Article · Source: Bloomberg Law
August 21, 2020
How To Launch a Femtech/Telehealth Start Up
Client Alert
August 17, 2020
Federal Government Takes Steps Toward Enforcement of ClinicalTrials.gov Requirements
Newsletter
August 17, 2020
Health Headlines – August 17, 2020
Newsletter
August 10, 2020
Health Headlines – August 10, 2020
Newsletter
August 3, 2020
Health Headlines – August 3, 2020
Client Alert
July 30, 2020
Trump Administration Continues to Promote Drug Importation as a Way to Lower the Cost of Prescription Drugs
Newsletter
July 27, 2020
Health Headlines – July 27, 2020
Newsletter
July 20, 2020
Health Headlines – July 20, 2020
Newsletter
July 13, 2020
Health Headlines – July 13, 2020
Newsletter
July 6, 2020
Health Headlines – July 6, 2020
Client Alert
Newsletter
June 29, 2020
Health Headlines – June 29, 2020
Client Alert
June 23, 2020
New Risks, New Rewards, New Exposure
Newsletter
June 15, 2020
Health Headlines – June 15, 2020
Article · Source: Law360
June 10, 2020
COVID-19 Vaccine Developers Can Limit Liability From Trials
Client Alert
June 8, 2020
Criminal and Civil Enforcement of the Defense Production Act
Newsletter
June 8, 2020
Health Headlines – June 8, 2020
Newsletter
June 1, 2020
Health Headlines – June 1, 2020
Newsletter
May 26, 2020
Health Headlines – May 26, 2020
Newsletter
May 18, 2020
Health Headlines – May 18, 2020
Article · Source: Bloomberg Law
May 12, 2020
Steps to Limit Exposure to Pharma, PPE Shareholder Lawsuits
Newsletter
May 6, 2020
Health Headlines – May 4, 2020
Client Alert
April 30, 2020
Congress Enacts OTC Monograph Reform
Newsletter
April 27, 2020
Health Headlines - April 27, 2020
Client Alert
April 24, 2020
One More Year: EU Medical Device Regulation Fully Applies on May 26, 2021
Client Alert
April 17, 2020
Europe Update – Life Sciences Products and COVID-19: From Clinical Trials to Regulatory Flexibility
Client Alert
Newsletter
April 13, 2020
Health Headlines – April 13, 2020
Newsletter
April 6, 2020
Health Headlines – April 6, 2020
Newsletter
March 30, 2020
Health Headlines – March 30, 2020
Client Alert
March 24, 2020
Tort Immunity under PREP Act and COVID-19 Response Declaration
Client Alert
March 23, 2020
U.S. and EU Regulators and Institutions Issue Guidance on Clinical Trial Conduct during COVID-19 Pandemic
Newsletter
March 23, 2020
Health Headlines – March 23, 2020
Client Alert
March 19, 2020
FDA Regulatory Issues for Automakers Manufacturing Medical Devices
Article · Source: Law360
March 19, 2020
Ruling In HHS Case May Mean More Drug Trial Reporting
Client Alert
March 16, 2020
CMS Releases Section 1135 Waiver in Response to the Novel Coronavirus Pandemic
Newsletter
March 16, 2020
Health Headlines – March 16, 2020
Client Alert
March 10, 2020
FDA Releases Progress Report Regarding Enforcement Discretion Policy on Hemp-Derived Cannabidiol (CBD)
Newsletter
March 9, 2020
Health Headlines – March 9, 2020
Client Alert
Article · Source: Law360
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
Newsletter
March 2, 2020
Health Headlines – March 2, 2020
Article · Source: Chambers and Partners
March 2, 2020
Chambers Global Practice Guide: Pharmaceutical Advertising
Thought Leadership
February 28, 2020
Heather Bañuelos to Co-Chair Food and Drug Law Institute’s 2020 Advertising and Promotion for Medical Products Conference
Client Alert
February 28, 2020
2019 Year in Review: FDA Office of Prescription Drug Promotion
Client Alert
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
Newsletter
February 24, 2020
Health Headlines – February 24, 2020
Newsletter
February 17, 2020
Health Headlines – February 17, 2020